Yahoo Finance

Scribe Achieves Milestone for In Vivo Program in Collaboration with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division, and Announces ASGCT Joint Presentation on ...

ALAMEDA, Calif., April 28, 2025--(BUSINESS WIRE)--Scribe Therapeutics Inc., a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced the achievement of ...
Seeking Alpha

Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone

RA'ANANA, Israel, Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology ...
Seeking Alpha

Scribe Achieves Milestone for In Vivo Program in Collaboration with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division, and Announces ASGCT Joint Presentation on ...

Success milestone reached in Scribe and Prevail’s ongoing collaboration to accelerate in vivo therapeutics for neurological and neuromuscular diseases using Scribe’s CRISPR technology Companies to ...